Other Insights from FSI

Breast Biopsy US & International Market Assessment
AI-Enabled Cardiac Device European Market Entry Strategy
Urinary Stone Management US & European Market Assessment
Digital Health Innovation Program Curriculum & Partnerships
Medical Device Company Expansion into Software Solutions
Academic Medical Center Innovation Conference Support

This paper lays out FSI's funnel for sizing the reachable population behind a first-in-class asset, the diagnostic and payer readiness gaps that delay adoption, and five questions to answer before a Phase 3 commitment.

Why capital is flowing to neuroscience companies that can show commercial differentiation on top of positive clinical data.